Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin E Gore

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|October 31, 2002
Biochemotherapy for advanced melanomaUlrich Keilholz, Martin E Gore
Oncology (Williston Park, N.Y.)|June 16, 2006
Emerging efficacy endpoints for targeted therapies in advanced renal cell carcinomaMartin E Gore, Bernard Escudier
Therapeutic Advances in Urology|December 2, 2016
Sunitinib in the treatment of metastatic renal cell carcinomaThomas A Schmid, Martin E Gore
BJU International|February 19, 2008
Establishing the role of cytokine therapy in advanced renal cell carcinomaMartin E Gore, Pieter De Mulder
Expert Review of Anticancer Therapy|December 26, 2006
New drug therapies for advanced renal cell carcinomaMartin E Gore, Michelle L Harrison, Ana Montes
AJR. American Journal of Roentgenology|July 25, 2007
Imaging in metastatic renal cell carcinomaNyree Griffin, Martin E Gore, S Aslam Sohaib
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
Nature Clinical Practice. Oncology|July 28, 2007
Drug insight: advances in renal cell carcinoma and the role of targeted therapiesJames M G Larkin, Simon Chowdhury, Martin E Gore
The Oncologist|November 6, 2010
Fatigue in renal cell carcinoma: the hidden burden of current targeted therapiesJames M G Larkin, Lynda M Pyle, Martin E Gore
BJU International|September 4, 2012
Endobronchial metastases from renal cell carcinoma: a late manifestation of the disease with an increasing incidenceMuhammad A Khattak, Rosalie A Fisher, Lisa M Pickering, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|October 31, 2002
Biochemotherapy for advanced melanomaUlrich Keilholz, Martin E Gore
Oncology (Williston Park, N.Y.)|June 16, 2006
Emerging efficacy endpoints for targeted therapies in advanced renal cell carcinomaMartin E Gore, Bernard Escudier
Therapeutic Advances in Urology|December 2, 2016
Sunitinib in the treatment of metastatic renal cell carcinomaThomas A Schmid, Martin E Gore
BJU International|February 19, 2008
Establishing the role of cytokine therapy in advanced renal cell carcinomaMartin E Gore, Pieter De Mulder
Expert Review of Anticancer Therapy|December 26, 2006
New drug therapies for advanced renal cell carcinomaMartin E Gore, Michelle L Harrison, Ana Montes
AJR. American Journal of Roentgenology|July 25, 2007
Imaging in metastatic renal cell carcinomaNyree Griffin, Martin E Gore, S Aslam Sohaib
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
Nature Clinical Practice. Oncology|July 28, 2007
Drug insight: advances in renal cell carcinoma and the role of targeted therapiesJames M G Larkin, Simon Chowdhury, Martin E Gore
The Oncologist|November 6, 2010
Fatigue in renal cell carcinoma: the hidden burden of current targeted therapiesJames M G Larkin, Lynda M Pyle, Martin E Gore
BJU International|September 4, 2012
Endobronchial metastases from renal cell carcinoma: a late manifestation of the disease with an increasing incidenceMuhammad A Khattak, Rosalie A Fisher, Lisa M Pickering, et al.
Pageof 6